Search Results - "Phelps, Janet R"
-
1
Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes
Published in Molecular therapy (01-02-2006)“…The systemic application of nucleic acid drugs requires delivery systems that overcome the poor pharmacokinetics, limited biodistribution, and inefficient…”
Get full text
Journal Article -
2
Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference
Published in The Journal of infectious diseases (15-06-2006)“…BackgroundEbola virus (EBOV) infection causes a frequently fatal hemorrhagic fever (HF) that is refractory to treatment with currently available antiviral…”
Get full text
Journal Article -
3
Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506
Published in Bioorganic & medicinal chemistry letters (01-10-2023)“…[Display omitted] Disruption of the HBV capsid assembly process through small-molecule interaction with HBV core protein is a validated target for the…”
Get full text
Journal Article -
4
Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein
Published in Antiviral research (01-01-2022)“…AB-506, a small-molecule inhibitor targeting the HBV core protein, inhibits viral replication in vitro (HepAD38 cells: EC50 of 0.077 μM, CC50 > 25 μM) and in…”
Get full text
Journal Article -
5
The identification of highly efficacious functionalised tetrahydrocyclopenta[]pyrroles as inhibitors of HBV viral replication through modulation of HBV capsid assembly
Published in RSC medicinal chemistry (23-03-2022)“…Disruption of the HBV viral life cycle with small molecules that prevent the encapsidation of pregenomic RNA and viral polymerase through binding to HBV core…”
Get full text
Journal Article -
6
ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection
Published in ACS infectious diseases (10-05-2019)“…Current approved nucleoside analogue treatments for chronic hepatitis B virus (HBV) infection are effective at controlling viral titer but are not curative and…”
Get full text
Journal Article -
7
Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation
Published in Antimicrobial agents and chemotherapy (01-06-2018)“…AB-423 is a member of the sulfamoylbenzamide (SBA) class of hepatitis B virus (HBV) capsid inhibitors in phase 1 clinical trials. In cell culture models,…”
Get full text
Journal Article